The association between microRNA polymorphisms and the risk of childhood acute lymphoblastic leukemia: A meta-analysis.

Case-control study Childhood acute lymphoblastic leukemia Meta-analysis MicroRNA Polymorphism

Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 04 05 2022
revised: 25 09 2022
accepted: 10 10 2022
pubmed: 8 11 2022
medline: 8 11 2022
entrez: 7 11 2022
Statut: ppublish

Résumé

The aim of this meta-analysis was to determine the relationship between microRNA polymorphisms and the risk of childhood acute lymphoblastic leukemia comprehensively. PubMed, EMBASE, Scopus, Web of Science, the Cochrane Library, Global Index Medicus, Clinicaltrials.gov, ProQuest, and Open Grey databases were used to find relevant papers. Using the STATA 16.0 and CMA 3.0 software, the significance of relationships between microRNA polymorphisms and childhood acute lymphoblastic leukemia risk was evaluated using odds ratios (ORs) and 95 % confidence intervals (95 % CIs) for five genetic models. The results of the meta-analysis showed that there was no significant association between the polymorphism of miR-146a rs2910164 and childhood acute lymphoblastic leukemia risk in different genetic models. Also, in the sensitivity analysis, removing Xue's study from the analysis indicated that both the homozygote and recessive models are significantly affected. Additionally, there was a statistically significant relationship between the polymorphisms of pri-miR-34b/c rs4938723 (in the homozygote and recessive models) and miR-612 rs12803915 (in the allele and dominant models) and childhood acute lymphoblastic leukemia risk. These findings suggest that the rs4938723 and rs12803915 polymorphisms may have a role in the development of childhood acute lymphoblastic leukemia.

Identifiants

pubmed: 36343468
pii: S1877-7821(22)00190-4
doi: 10.1016/j.canep.2022.102285
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102285

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no competing interests.

Auteurs

Abbas Navabi (A)

Student Research Committee, School of Medical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mozaffar Aznab (M)

Medical Oncologist-Hematologist, Internal Medicine Department, Talaghani Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Fatemeh Heydarpour (F)

Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address: FATEMEH_HYDARPUR@yahoo.com.

Classifications MeSH